Characterization of the cell of origin and propagation potential of the fibroblast growth factor 9-induced mouse model of lung adenocarcinoma-Reference-Cited by-同舟云学术

Characterization of the cell of origin and propagation potential of the fibroblast growth factor 9-induced mouse model of lung adenocarcinoma

Published:2014-12-17 Issue:4 Volume:235 Page:593-605
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol.

Author:

Arai Daisuke¹,Hegab Ahmed E¹,Soejima Kenzo¹,Kuroda Aoi¹,Ishioka Kota¹,Yasuda Hiroyuki¹,Naoki Katsuhiko¹,Kagawa Shizuko¹,Hamamoto Junko¹,Yin Yongjun²,Ornitz David M²,Betsuyaku Tomoko¹

Affiliation:

1. Division of Pulmonary Medicine, Department of Medicine; Keio University School of Medicine; Tokyo Japan

2. Department of Developmental Biology; Washington University School of Medicine; St. Louis USA

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/path.4486/fullpdf

Reference45 articles.

1. Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing;Imielinski;Cell,2012

2. Somatic mutations affect key pathways in lung adenocarcinoma;Ding;Nature,2008

3. Activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor are associated with improved survival in gefitinib-treated chemorefractory lung adenocarcinomas;Taron;Clin Cancer Res,2005

4. Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancers dependent on the epidermal growth factor receptor pathway;Nguyen;Clin Lung Cancer,2009

5. The frequency of EGFR and KRAS mutations in non-small cell lung cancer (NSCLC): routine screening data for central Europe from a cohort study;Boch;BMJ Open,2013

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FGF9, a Potent Mitogen, Is a New Ligand for Integrin αvβ3, and the FGF9 Mutant Defective in Integrin Binding Acts as an Antagonist;Cells;2024-02-07

2. Signaling pathway and pharmacology;Fibroblast Growth Factors;2024

3. FGF9, a potent mitogen, is a new ligand for integrin αvβ3, and the FGF9 mutant defective in integrin binding acts as an antagonist;2023-12-02

4. FGF/FGFR signaling: From lung development to respiratory diseases;Cytokine & Growth Factor Reviews;2021-12

5. Upregulation of FGF9 in Lung Adenocarcinoma Transdifferentiation to Small Cell Lung Cancer;Cancer Research;2021-06-03